Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Roots Analysis | PRODUCT CODE: 1101050

Cover Image

PUBLISHER: Roots Analysis | PRODUCT CODE: 1101050

Needlestick Safety Injection Devices Market by Type of Device, Purpose of Device, Usability, Company Size and Key Geographical Regions : Industry Trends and Global Forecasts, 2022-2035

PUBLISHED:
PAGES: 192 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4799
PDF (One-Location Site License)
USD 6999
PDF (Department License)
USD 10599
PDF (Enterprise License)
USD 17999

Add to Cart

INTRODUCTION

According to a study published in the Canadian Journal of Infectious Disease and Medical Microbiology in 2021, more than 1.3 million cases of needlestick injuries (NSI) among health care workers (HCWs) are reported every year in the US and Europe. NSIs are known to occur frequently in healthcare settings while using injections and can lead to transmission of various blood borne pathogen. In fact, as per the estimates provided by the Centers for Disease Control and Prevention (CDC), HCWs are at an increased risk of exposure to harmful pathogens, such as human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus, due to needlesticks. Some of the common factors that are believed to be the cause for high number of NSIs include inessential use of sharp devices, inadequacy of personal protective equipment, lack of training, and inappropriate disposal of sharp devices and needles. In order to reduce the number of such cases, several initiatives have been undertaken to ensure safety of HCWs and patients, which include the launch of 2010 EU directive initiative on sharps injury prevention by the European Union and development of smart needles and advanced injection devices. Since the use of needles is unavoidable in healthcare, device developers have come up with highly advanced product designs and safety measurements to limit the risk posed by sharp needles. These safety injection devices have several advantages, including needle shielding and automatic retraction of needles into the syringe barrel when the plunger is released, and easy disposal of safety needle.

Given the various benefits of needlestick safety injection devices, several companies have developed and launched their proprietary smart devices that are capable of preventing injuries caused by needlesticks along with reducing the transmission of infectious diseases. In addition, in order to expand the reach of their devices and enhance their product portfolios, players in this domain are actively collaborating with other stakeholders. Moreover, the stakeholders have undertaken several initiatives to augment their intellectual portfolio with an intention to incorporate advanced features to their products. Driven by the growing demand for safe and efficient drug delivery systems and ongoing efforts by the players to integrate sophisticated features in the product design and technology, the needlestick safety injection devices market is likely to witness noteworthy growth over the coming years.

SCOPE OF THE REPORT

The "Needlestick Safety Injection Devices Market by Type of Device (Needles, Syringes, and Other types of devices), Purpose of Device (Needle Shielding, Protection against Injuries, and Enabling ease of Needle Insertion / Retraction), Usability (Non-Reusable and Reusable), Company Size (Very Large, Large, Mid-sized, Small and Very Small) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035" report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of the needlestick safety injection devices (either commercialized or under development) in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:

  • A detailed assessment of the market landscape of needlestick safety injection devices based on several relevant parameters, such as type of device (needle, syringe, and other types of devices), purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding), usability (non-reusable and reusable), mode of sterilization (ethylene oxide, gamma rays, steam and other methods) and packaging format (box, tub, and other packaging formats). In addition, it features analysis of the companies engaged in the development / deployment of needlestick safety injection devices, along with information on their year of establishment, company size, location of headquarters, and leading players (in terms of number of needlestick safety injection devices developed).
  • An in-depth key insights analysis, highlighting the contemporary market trends using impactful schematic representations, including a tree map representation, based on type of device (needle, syringe, and other types of devices) and company size, a waffle chart representation, based on purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding) and company size, a 4D bubble analysis, which compares the capabilities of leading players engaged in the development / deployment of needlestick safety injection devices, based on various parameters, such as type of device (needle, syringe, and other types of devices), purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding), company size and location of headquarters (region-wise), a world map representation, highlighting the regional distribution of leading players engaged in the development / deployment of needlestick safety injection devices and a grid representation, based on type of device, purpose of device and usability.
  • A detailed product competitiveness analysis of needlestick safety injection devices, based on supplier power (based on the experience of the developer in this industry) and key specifications of products, including purpose of device (enabling ease of needle insertion / retraction, protection against injuries and needle shielding), usability (non-reusable and reusable), mode of sterilization (gamma rays, ethylene oxide, steam, and other methods).
  • An in-depth analysis of various initiatives undertaken in this domain, during the period 2016-2022, wherein companies have entered into partnerships with other stakeholders related to needlestick safety injection devices and the related recent events (conferences / seminars / webinars / workshops) organized by several stakeholders, across the globe. In addition, it provides information on the funding activity in this domain, highlighting the involvement of venture capitalists and funding schemes of various public and private organizations / funds that have allowed start-ups / small companies to expand their capabilities.
  • An analysis of the patents filed / granted for needlestick safety injection devices, since 2018, taking into consideration several relevant parameters, such as type of patent, publication year, application year, issuing authority, geographical location, Cooperative Patent Classification (CPC) symbols, emerging focus areas, type of organization, leading industry and non-industry players (on the basis of number of patents filed / granted) and individual patent assignees (in terms of size of intellectual property portfolio), patent benchmarking, patent characteristics and age of patents. In addition, the chapter also includes an insightful patent valuation analysis and leading patents by number of citations.
  • Elaborate profiles of key players engaged in the development of needlestick safety injection devices. Each profile features a brief overview of the company, details on its product portfolio, recent developments and an informed future outlook. Additionally, it provides a detailed scoring matrix of leading players profiled in this chapter (based on the recent initiatives).
  • A Bowman's strategy clock framework to understand the pricing strategy of the needlestick safety injection devices developed by the company along with its competitive position in the marketplace. In addition, it presents the equation devised to calculate the likely price of the needlestick safety injection devices based upon their features.

One of the key objectives of the report was to evaluate the existing market size, primary growth factors and future opportunity within the needlestick safety injection devices market in the mid to long term. Our year-wise projections of the current and future opportunity within the needlestick safety injection devices market have further been segmented across types of devices (needles, syringes, and other types of devices), purposes of devices (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding), usability (reusable and non-reusable), company size of developers (very small, small, mid-sized, large and very large) and geographical regions (North America, Europe, Asia-Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry's growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary research. For all our projects, we conduct interviews / surveys with experts in the area (academia, industry and other associations) to solicit their opinions on emerging trends in the market. This information is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been validated from multiple sources of information.

The secondary sources of information include:

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy documents
  • Industry analysts' views

While the focus has been on forecasting the market till 2035, the report also provides our independent views on various non-commercial trends emerging in this industry. The opinions are solely based on our knowledge, research and understanding of the relevant market trends gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

  • Who are the leading players engaged in the development of needlestick safety injection devices?
  • Which are the popular types of safety injection devices available in the market?
  • What are the key challenges associated with the development of needlestick safety injection devices?
  • Which type of partnership models are commonly being adopted by industry stakeholders?
  • How has the intellectual property landscape of needlestick safety injection devices developers evolved over the years?
  • What factors are likely to influence the evolution of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

CHAPTER OUTLINES

  • Chapter 2 is an executive summary of the key insights captured during our research. It offers a high-level view on the current state of the needlestick safety injection devices market and its likely evolution in the mid to long term.
  • Chapter 3 provides a general introduction to needlestick safety injection devices, types of needle-stick safety injection devices and their advantages. In addition, the chapter provides an overview on the growing relevance of the safety injection devices, as potential solutions to limit the injuries caused by the use of conventional needles. Further, the chapter presents an array of Google trends analysis, highlighting the emerging focus areas, key historical trends, and geographical activity, offering insights on how this field has evolved over the last five years.
  • Chapter 4 presents a detailed assessment of the market landscape of around 140 needlestick safety injection devices, based on several relevant parameters, such as type of device (needle, syringe, and other types of devices), purpose of devices (enabling ease of needle insertion / retraction, protection against injuries and needle shielding), usability (reusable and non-reusable), mode of sterilization (ethylene oxide, gamma rays, steam and other methods), and packaging format (box, tub, and other packaging formats). In addition, it presents analysis on the companies engaged in the development / deployment of needlestick safety injection devices, along with information on their year of establishment, company size, location of headquarters. Further, it highlights the leading players (in terms of number of needlestick safety injection devices developed) in this domain.
  • Chapter 5 presents an in-depth key insights analysis, highlighting the contemporary market trends using impactful schematic representations, including [A] a tree map representation, based on type of device (needle, syringe, and other types of devices) and company size, [B] a waffle chart representation, based on purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding) and company size, [C] a 4D bubble analysis, which compares the capabilities of leading players engaged in the development / deployment of needlestick safety injection devices, based on various parameters, such as type of device (needle, syringe, and other types of devices), purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding), company size and location of headquarters (region-wise), [D] a world map representation, highlighting the regional distribution of leading players engaged in the development / deployment of needlestick safety injection devices and [E] a grid representation, based on type of device, purpose of device and usability.
  • Chapter 6 is an insightful product competitiveness analysis of needlestick safety injection devices, based on supplier power (based on the experience of the developer in this industry) and key specifications of products, including purpose of device (enabling ease of needle insertion / retraction, protection against injuries and needle shielding), usability (non-reusable and reusable), and mode of sterilization (ethylene oxide, gamma, steam, and other methods).
  • Chapter 7 features an in-depth analysis of various initiatives undertaken in this domain, during the period 2016-2022, wherein companies have entered into partnerships with other stakeholders related to needlestick safety injection devices and the related recent events (conferences / seminars / webinars / workshops) organized by several stakeholders, across the globe. In addition, it provides information on the funding activity in this domain, highlighting the involvement of venture capitalists and funding schemes of various public and private organizations / funds that have allowed start-ups / small companies to expand their capabilities.
  • Chapter 8 provides an insightful analysis of the patents filed / granted for needlestick safety injection devices, since 2018, taking into consideration several relevant parameters, such as type of patent, publication year, application year, issuing authority, geographical location, Cooperative Patent Classification (CPC) symbols, emerging focus areas, leading industry and non-industry players (on the basis of number of patents) and individual patent assignees (in terms of size of intellectual property portfolio), patent benchmarking, patent characteristics and age of patents. In addition, the chapter also includes an insightful patent valuation analysis and leading patents by number of citations.
  • Chapter 9 provides detailed profiles of key players engaged in the development of needlestick safety injection devices. Each profile features a brief overview of the company, details on its product portfolio, recent developments and an informed future outlook. Additionally, it provides a detailed scoring matrix of leading players profiled in this chapter (based on the recent initiatives).
  • Chapter 10 presents a Bowman's strategy clock framework to understand the pricing strategy of the needlestick safety injection devices developed by the company along with its competitive position in the marketplace. In addition, it presents the equation devised to calculate the likely price of the needlestick safety injection devices based upon their features.
  • Chapter 11 features an insightful market forecast analysis, highlighting the likely growth of the needlestick safety injection devices market, till the year 2035. In addition, we estimated the likely distribution of the current and forecasted opportunity across various types of devices (needles, syringes, and other types of devices), purposes of devices (needle shielding, protection against injuries, and enabling ease of needle insertion / retraction), usability (non-reusable and reusable), company size of developers (very large, large, mid-sized, small and very small) and geographical regions (North America, Europe, Asia-Pacific and rest of the world).
  • Chapter 12 is a summary of the overall report, highlighting various facts related to contemporary market trend and the likely evolution of the needlestick safety injection devices market.
  • Chapter 13 is an appendix that contains tabulated data and numbers for all the figures in the report.
  • Chapter 14 is an appendix that provides the list of companies and organizations mentioned in the report.
Product Code: RA100360

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Concern of Needlestick Injuries
  • 3.3. Need for Needlestick Safety Injection Devices
  • 3.4. Classification of Needlestick Safety Injection Devices
  • 3.5. Advantages and Limitations of Needlestick Safety Injection Devices
  • 3.6. Prevalent Trends related to Needlestick Safety Injection Devices
    • 3.6.1. Key Historical Trends
    • 3.6.2. Emerging Focus Areas
    • 3.6.3. Geographical Activity

4. NEEDLESTICK SAFETY INJECTION DEVICES: MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Needlestick Safety Injection Devices: Market Landscape
    • 4.2.1. Analysis by Type of Device
    • 4.2.2. Analysis by Purpose of Device
    • 4.2.3. Analysis by Usability
    • 4.2.4. Analysis by Mode of Sterilization
    • 4.2.5. Analysis by Packaging Format
  • 4.3. Needlestick Safety Injection Devices: Developer Landscape
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Location of Headquarters
    • 4.3.4. Leading Players: Analysis by Number of Needlestick Safety Injection Devices

5. KEY INSIGHTS

  • 5.1. Chapter Overview
  • 5.2. Tree Map Representation: Analysis by Type of Device and Company Size
  • 5.3. Waffle Chart: Analysis by Purpose of Device and Company Size
  • 5.4. 4D Bubble Analysis: Analysis by Portfolio Strength, Purpose of Device, Company Size and Location of Headquarters
  • 5.5. World Map Representation: Analysis by Location of Headquarters
  • 5.6. Grid Representation: Analysis by Type of Device, Purpose of Device and Usability

6. PRODUCT COMPETITIVENESS ANALYSIS

  • 6.1. Chapter Overview
  • 6.2. Assumptions / Key Parameters
  • 6.3. Methodology
  • 6.4. Product Competitiveness Analysis
    • 6.4.1. Needlestick Safety Injection Devices: Needles
    • 6.4.2. Needlestick Safety Injection Devices: Syringes
    • 6.4.3. Needlestick Safety Injection Devices: Other Types of Devices

7. RECENT DEVELOPMENTS AND INITIATIVES

  • 7.1. Chapter Overview
  • 7.2. Needlestick Safety Injection Devices: Partnerships and Collaborations
    • 7.2.1. Partnership Models
    • 7.2.2. List of Partnerships and Collaborations
    • 7.2.3. Analysis by Year of Partnership
    • 7.2.4. Analysis by Type of Partnership
    • 7.2.5. Analysis by Type of Partner
    • 7.2.6. Word Cloud Analysis: Emerging Focus Areas
    • 7.2.7. Analysis by Type of Device
    • 7.2.8. Analysis by Type of Agreement (Country-wise)
    • 7.2.9. Analysis by Type of Agreement (Region-wise)
    • 7.2.10. Most Active Players: Analysis by Number of Partnerships
  • 7.3 Needlestick Safety Injection Devices: Funding and Investments
    • 7.3.1. Types of Funding and Investments
    • 7.3.2. List of Funding and Investments
    • 7.3.3. Analysis by Year of Investment
    • 7.3.4. Analysis by Type of Funding
    • 7.3.5. Analysis by Amount Invested
    • 7.3.6. Most Active Players: Analysis by Number of Funding Instances
    • 7.3.7. Most Active Players: Analysis by Amount Raised
    • 7.3.8. Analysis by Type of Device
    • 7.3.9. Analysis by Region
  • 7.4 Needlestick Safety Injection Devices: Global Events
    • 7.4.1 List of Global Events
    • 7.4.2. Analysis by Year of Global Event
    • 7.4.3. Analysis by Type of Global Event (Virtual / Physical)
    • 7.4.4. Analysis by Type of Global Event (Conference / Webinar / Summit)
    • 7.4.5. Analysis by Geography
    • 7.4.6. Most Active Event Organizers: Analysis by Number of Events
    • 7.4.7. Most Active Participants: Analysis by Number of Events
    • 7.4.8. Analysis by Seniority Level of Participants

8. PATENT ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Methodology and Key Parameters
  • 8.3. Needlestick Safety Injection Devices: Patent Analysis
    • 8.3.1. Analysis by Type of Patent
    • 8.3.2. Analysis by Patent Publication Year
    • 8.3.3. Analysis by Application Year
    • 8.3.4. Analysis by Geographical Location
    • 8.3.5. Analysis by CPC Symbols
    • 8.3.6. Word Cloud Analysis: Emerging Focus Areas
    • 8.3.7. Analysis by Type of Organization
    • 8.3.8. Leading Industry Players: Analysis by Number of Patents
    • 8.3.9. Leading Patent Assignees: Analysis by Number of Patents
  • 8.4. Needlestick Safety Injection Devices: Patent Benchmarking Analysis
    • 8.4.1. Analysis by Patent Characteristics (CPC Symbols)
  • 8.5 Analysis of Patents by Age
  • 8.6. Patent Valuation Analysis
  • 8.7. Leading Patents by Number of Citations

9. COMPANY PROFILES

  • 9.1. Chapter Overview
  • 9.2. B. Braun
    • 9.2.1. Company Overview
    • 9.2.2. Product Portfolio: Needlestick Safety Injection Devices
    • 9.2.3. Recent Developments and Future Outlook
  • 9.3. BD
    • 9.3.1. Company Overview
    • 9.3.2. Product Portfolio: Needlestick Safety Injection Devices
    • 9.3.3. Recent Developments and Future Outlook
  • 9.4. Gerresheimer
    • 9.4.1. Company Overview
    • 9.4.2. Product Portfolio: Needlestick Safety Injection Devices
    • 9.4.3. Recent Developments and Future Outlook
  • 9.5. HTL-STREFA
    • 9.5.1. Company Overview
    • 9.5.2. Product Portfolio: Needlestick Safety Injection Devices
    • 9.5.3. Recent Developments and Future Outlook
  • 9.6. Nipro Europe Group Companies
    • 9.6.1. Company Overview
    • 9.6.2. Product Portfolio: Needlestick Safety Injection Devices
    • 9.6.3. Recent Developments and Future Outlook
  • 9.7. SOL-MILLENNIUM Medical Group
    • 9.7.1. Company Overview
    • 9.7.2. Product Portfolio: Needlestick Safety Injection Devices
    • 9.7.3. Recent Developments and Future Outlook
  • 9.8. Conclusion: Leading Players

10. BOWMAN CLOCK PRICING STRATEGY

  • 10.1. Chapter Overview
  • 10.2. Bowman Strategy Clock
  • 10.3. Two Dimensions of Bowman Strategy Clock
  • 10.4. Eight Positions on Bowman Strategy Clock
  • 10.5. Roots Analysis Framework
  • 10.6. Methodology
  • 10.7. Theoretical Framework and Price Evaluation Hypothesis
  • 10.8. Results and Interpretation
    • 10.8.1. Product Price Evaluation Matrix: Needles
    • 10.8.2. Product Price Evaluation Matrix: Syringes
    • 10.8.3. Product Price Evaluation Matrix: Other Types of Devices
  • 10.9. Case Study: Pricing of Marketed Products

11. MARKET FORECAST

  • 11.1. Chapter Overview
  • 11.2. Forecast Methodology and Key Assumptions
  • 11.3. Global Needlestick Safety Injection Devices Market, 2022-2035
    • 11.3.1. Global Needlestick Safety Injection Devices Market: Distribution by Type of Device
      • 11.3.1.1. Global Needlestick Safety Injection Devices Market for Needles
      • 11.3.1.2. Global Needlestick Safety Injection Devices Market for Syringes
      • 11.3.1.3. Global Needlestick Safety Injection Devices Market for Other Types of Devices
    • 11.3.2. Global Needlestick Safety Injection Devices Market: Distribution by Purpose of Device
      • 11.3.2.1. Global Needlestick Safety Injection Devices Market for Devices Enabling Ease of Insertion / Retraction
      • 11.3.2.2. Global Needlestick Safety Injection Devices Market for Needle Shielding Devices
      • 11.3.2.3. Global Needlestick Safety Injection Devices Market for Devices Protecting Against Injuries
    • 11.3.3. Global Needlestick Safety Injection Devices Market: Distribution by Usability
      • 11.3.3.1. Global Needlestick Safety Injection Devices Market for Non-Reusable Devices
      • 11.3.3.2. Global Needlestick Safety Injection Devices Market for Reusable Devices
    • 11.3.4. Global Needlestick Safety Injection Devices Market: Distribution by Company Size
      • 11.3.4.1. Global Needlestick Safety Injection Devices Market for Very Small Companies
      • 11.3.4.2. Global Needlestick Safety Injection Devices Market for Small Companies
      • 11.3.4.3. Global Needlestick Safety Injection Devices Market for Mid-sized Companies
      • 11.3.4.4. Global Needlestick Safety Injection Devices Market for Large Companies
      • 11.3.4.5. Global Needlestick Safety Injection Devices Market for Very Large Companies
    • 11.3.5 Global Needlestick Safety Injection Devices Market: Distribution by Region, 2022 and 2035
      • 11.3.5.1. Needlestick Safety Injection Devices Market in North America, 2022-2035
      • 11.3.5.2. Needlestick Safety Injection Devices Market in Europe, 2022-2035
      • 11.3.5.3. Needlestick Safety Injection Devices Market in Asia Pacific, 2022-2035
      • 11.3.5.4. Needlestick Safety Injection Devices in Rest of the World, 2022-2035

12. CONCLUDING REMARKS

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Product Code: RA100360

LIST OF TABLES

  • Table 4.1 Needlestick Safety Injection Devices: Information on Type of Device
  • Table 4.2 Needlestick Safety Injection Devices: Information on Purpose of Device
  • Table 4.3 Needlestick Safety Injection Devices: Information on Usability and Mode of Sterilization
  • Table 4.4 Needlestick Safety Injection Devices: Information on Mode of Sterilization, Packaging Format, and Price (USD)
  • Table 4.5 Needlestick Safety Injection Devices: Information on Developers
  • Table 7.1 Partnerships and Collaborations: Information on Year of Partnership, Type of Partnership and Partner, 2016-2022
  • Table 7.2 Funding and Investments: Information on Year of Establishment, Location of Headquarters of Recipients, Month-Year of Investment, Type of Funding, Amount Invested, Lead Investor(s) and Type of Device, 2016-2022
  • Table 7.3 Needlestick Safety Injection Devices List of Global Events
  • Table 8.1 Patent Analysis: Prominent CPC Symbols
  • Table 8.2 Patent Analysis: List of Top CPC Symbols
  • Table 8.3 Patent Analysis: Most Popular CPC Symbols
  • Table 8.4 Patent Analysis: Summary of Benchmarking Analysis
  • Table 8.5 Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 8.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
  • Table 8.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
  • Table 9.1 Needlestick Safety Injection Device Developers: List of Companies Profiled
  • Table 9.2 B. Braun: Company Overview
  • Table 9.3 B. Braun: Needlestick Safety Injection Devices Portfolio
  • Table 9.4 B. Braun: Recent Developments and Future Outlook
  • Table 9.5 BD: Company Overview
  • Table 9.6 BD: Needlestick Safety Injection Devices Portfolio
  • Table 9.7 BD: Recent Developments and Future Outlook
  • Table 9.8 Gerresheimer: Company Overview
  • Table 9.9 Gerresheimer: Needlestick Safety Injection Devices Portfolio
  • Table 9.10 Gerresheimer: Recent Developments and Future Outlook
  • Table 9.11 HTL-STREFA: Company Overview
  • Table 9.12 HTL-STREFA: Needlestick Safety Injection Devices Portfolio
  • Table 9.13 HTL-STREFA: Recent Developments and Future Outlook
  • Table 9.14 Nipro Europe Group Companies: Company Overview
  • Table 9.15 Nipro Europe Group Companies: Needlestick Safety Injection Device Portfolio
  • Table 9.16 Nipro Europe Group Companies: Recent Developments and Future Outlook
  • Table 9.17 SOL-MILLENNIUM Medical Group: Company Overview
  • Table 9.18 SOL-MILLENNIUM Medical Group: Needlestick Safety Injection Device Portfolio
  • Table 9.19 SOL-MILLENNIUM Medical Group: Recent Developments and Future Outlook
  • Table 10.1 Product Price Evaluation Matrix: Needles (USD)
  • Table 10.2 Product Price Evaluation Matrix: Syringes (USD)
  • Table 10.3 Product Price Evaluation Matrix: Other Types of Devices (USD)
  • Table 14.1 Needlestick Safety Injection Devices: Distribution by Type of Device
  • Table 14.2 Needlestick Safety Injection Devices: Distribution by Purpose of Device
  • Table 14.3 Needlestick Safety Injection Devices: Distribution by Type of Device and Purpose of Device
  • Table 14.4 Needlestick Safety Injection Devices: Distribution by Usability
  • Table 14.5 Needlestick Safety Injection Devices: Distribution by Type of Device and Usability
  • Table 14.6 Needlestick Safety Injection Devices: Distribution by Mode of Sterilization
  • Table 14.7 Needlestick Safety Injection Devices: Distribution by Packaging Format
  • Table 14.8 Needlestick Safety Injection Devices Developers: Distribution by Year of Establishment
  • Table 14.9 Needlestick Safety Injection Devices Developers: Distribution by Company Size
  • Table 14.10 Needlestick Safety Injection Devices Developers: Distribution by Location of Headquarters
  • Table 14.11 Needlestick Safety Injection Devices Developers: Distribution by Company Size and Location of Headquarters
  • Table 14.12 Leading Players: Distribution by Number of Needlestick Safety Injection Devices
  • Table 14.13 Tree Map Representation: Distribution by Type of Device and Location of Headquarters
  • Table 14.14 Waffle Chart Representation: Distribution by Purpose of Device and Company Size
  • Table 14.15 4D Bubble Analysis: Distribution by Portfolio Strength, Purpose of Device, Company Size and Location of Headquarters
  • Table 14.16 World Map Representation: Distribution by Location of Headquarters
  • Table 14.17 Grid Representation: Distribution by Type of Device, Purpose of Device and Usability
  • Table 14.18 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2022
  • Table 14.19 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 14.20 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 14.21 Partnerships and Collaborations: Distribution by Type of Partner
  • Table 14.22 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
  • Table 14.23 Partnerships and Collaborations: Distribution by Type of Device
  • Table 14.24 Partnerships and Collaborations: Type of Agreement (Country-Wise)
  • Table 14.25 Partnerships and Collaborations: Type of Agreement (Region-Wise)
  • Table 14.26 Most Active Players: Distribution by Number of Partnerships
  • Table 14.27 Funding and Investment Analysis: Cumulative Year-wise Trend of Instances, 2016-2022
  • Table 14.28 Funding and Investment Analysis: Distribution of by Type of Funding
  • Table 14.29 Funding and Investment Analysis: Cumulative Year-wise Trend of Amount Invested (USD Million)
  • Table 14.30 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Table 14.31 Most Active Players: Distribution by Number of Funding Instances
  • Table 14.32 Most Active Players: Distribution by Amount Raised (USD Million)
  • Table 14.33 Funding and Investment Analysis: Distribution by Type of Device
  • Table 14.34 Funding and Investment Analysis: Type of Device and Amount Invested (USD Million)
  • Table 14.35 Funding and Investment Analysis: Regional Distribution
  • Table 14.36 Global Events: Cumulative Half Yearly Trend, H1 2016-H2 2021
  • Table 14.37 Global Events: Distribution by Type of Global Event (Virtual / Physical)
  • Table 14.38 Global Events: Distribution by Type of Global Event (Conference / Webinar / Summit)
  • Table 14.39 Global Events: Distribution by Location of Event
  • Table 14.40 Most Active Event Organizers: Distribution by Number of Events
  • Table 14.41 Most Active Participants: Distribution by Number of Events
  • Table 14.42 Global Events: Distribution by Seniority Level of Participants
  • Table 14.43 Patent Analysis: Distribution by Type of Patent
  • Table 14.44 Patent Analysis: Cumulative Distribution by Publication Year, 2018-2022
  • Table 14.45 Patent Analysis: Cumulative Distribution by Application Year, 2018-2022
  • Table 14.46 Patent Analysis: Distribution by Geographical Location
  • Table 14.47 Patent Analysis: Distribution by CPC Symbols
  • Table 14.48 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization
  • Table 14.49 Leading Industry Players: Distribution by Number of Patents
  • Table 14.50 Leading Patent Assignees: Distribution by Number of Patents
  • Table 14.51 Patent Analysis (Leading Industry Players): Benchmarking by Patent Characteristics (CPC Symbols)
  • Table 14.52 Patent Analysis: Distribution of Patents by Age (2001-2020)
  • Table 14.53 Needlestick Safety Injection Devices: Patent Valuation Analysis
  • Table 14.54 Global Needlestick Safety Injection Devices Market: Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
  • Table 14.55 Global Needlestick Safety Injection Devices Market: Distribution by Type of Device, Conservative, Base and Optimistic Scenarios, 2022 and 2035
  • Table 14.56 Global Needlestick Safety Injection Devices Market for Needles: Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.57 Global Needlestick Safety Injection Devices Market for Syringes: Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.58 Global Needlestick Safety Injection Devices Market for Other Types of Devices: Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.59 Global Needlestick Safety Injection Devices Market: Distribution by Purpose of Device, Conservative, Base and Optimistic Scenarios, 2022 and 2035
  • Table 14.60 Global Needlestick Safety Injection Devices Market for Devices Enabling Ease of Insertion / Retraction, Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.61 Global Needlestick Safety Injection Devices Market for Needle Shielding Devices, Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.62 Global Needlestick Safety Injection Devices Market for Devices Protecting Against Injuries, Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.63 Global Needlestick Safety Injection Devices Market: Distribution by Usability, Conservative, Base and Optimistic Scenarios, 2022 and 2035
  • Table 14.64 Global Needlestick Safety Injection Devices Market for Non-Reusable Devices: Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.65 Global Needlestick Safety Injection Devices Market for Reusable Devices: Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.66 Global Needlestick Safety Injection Devices Market: Distribution by Company Size, Conservative, Base and Optimistic Scenarios, 2022 and 2035
  • Table 14.67 Global Needlestick Safety Injection Devices Market for Very Small Companies: Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.68 Global Needlestick Safety Injection Devices Market for Small Companies: Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.69 Global Needlestick Safety Injection Devices Market for Mid-sized Companies: Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.70 Global Needlestick Safety Injection Devices Market for Large Companies: Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.71 Global Needlestick Safety Injection Devices Market for Very Large Companies: Conservative, Base and Optimistic Scenarios, 2022 and 2035 (USD Billion)
  • Table 14.72 Global Needlestick Safety Injection Devices Market: Distribution by Region: Conservative, Base and Optimistic Scenarios, 2022 and 2035
  • Table 14.73 Global Needlestick Safety Injection Devices Market in North America: Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 14.74 Global Needlestick Safety Injection Devices Market in Europe: Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 14.75 Global Needlestick Safety Injection Devices Market in Asia-Pacific: Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 14.76 Global Needlestick Safety Injection Devices Market in Rest of the World: Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)

LIST OF FIGURES

  • Figure 2.1 Executive Summary: Overall Market Landscape of Needlestick Safety Injection Devices
  • Figure 2.2 Executive Summary: Recent Developments and Initiatives
  • Figure 2.3 Executive Summary: Patent Analysis
  • Figure 2.4 Executive Summary: Market Forecast
  • Figure 3.1 Classification of Needlestick Safety Injection Devices
  • Figure 3.2 Advantages of Needlestick Safety Injection Devices
  • Figure 3.3 Limitations of Needlestick Safety Injection Devices
  • Figure 3.4 Emerging Focus Area: Google News
  • Figure 3.5 Google Trends: Historical Timeline
  • Figure 3.6 Google Trends: Geographical Activity
  • Figure 4.1 Needlestick Safety Injection Devices: Distribution by Type of Device
  • Figure 4.2 Needlestick Safety Injection Devices: Distribution by Purpose of Device
  • Figure 4.3 Needlestick Safety Injection Devices: Distribution by Type of Device and Purpose of Device
  • Figure 4.4 Needlestick Safety Injection Devices: Distribution by Usability
  • Figure 4.5 Needlestick Safety Injection Devices: Distribution by Type of Device and Usability
  • Figure 4.6 Needlestick Safety Injection Devices: Distribution by Mode of Sterilization
  • Figure 4.7 Needlestick Safety Injection Devices: Distribution by Packaging Format
  • Figure 4.8 Needlestick Safety Injection Devices Developers: Distribution by Year of Establishment
  • Figure 4.9 Needlestick Safety Injection Devices Developers: Distribution by Company Size
  • Figure 4.10 Needlestick Safety Injection Devices Developers: Distribution by Location of Headquarters
  • Figure 4.11 Needlestick Safety Injection Devices Developers: Distribution by Company Size and Location of Headquarters
  • Figure 4.12 Leading Players: Distribution by Number of Needlestick Safety Injection Devices
  • Figure 5.1 Tree Map Representation: Distribution by Type of Device and Location of Headquarters
  • Figure 5.2 Waffle Chart Representation: Distribution by Purpose of Device and Company Size
  • Figure 5.3 4D Bubble Analysis: Distribution by Portfolio Strength, Purpose of Device, Company Size and Location of Headquarters
  • Figure 5.4 World Map Representation: Distribution by Location of Headquarters
  • Figure 5.5 Grid Representation: Distribution by Type of Device, Purpose of Device and Usability
  • Figure 6.1 Product Competitiveness Analysis: Needle Safety Injection Devices
  • Figure 6.2 Product Competitiveness Analysis: Syringe Safety Injection Devices
  • Figure 6.3 Product Competitiveness Analysis: Other Safety Injection Devices
  • Figure 7.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2022
  • Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 7.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 7.4 Partnerships and Collaborations: Distribution by Type of Partner
  • Figure 7.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
  • Figure 7.6 Word Cloud Analysis: Emerging Focus Areas
  • Figure 7.7 Partnerships and Collaborations: Distribution by Type of Device
  • Figure 7.8 Partnerships and Collaborations: Type of Agreement (Country-Wise)
  • Figure 7.9 Partnerships and Collaborations: Type of Agreement (Region-Wise)
  • Figure 7.10 Most Active Players: Distribution by Number of Partnerships
  • Figure 7.11 Funding and Investment Analysis: Cumulative Year-wise Trend of Instances, 2016-2022
  • Figure 7.12 Funding and Investment Analysis: Distribution of by Type of Funding
  • Figure 7.13 Funding and Investment Analysis: Cumulative Year-wise Trend of Amount Invested (USD Million)
  • Figure 7.14 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Figure 7.15 Most Active Players: Distribution by Number of Funding Instances
  • Figure 7.16 Most Active Players: Distribution by Amount Raised (USD Million)
  • Figure 7.17 Funding and Investment Analysis: Distribution by Type of Device
  • Figure 7.18 Funding and Investment Analysis: Type of Device and Amount Invested (USD Million)
  • Figure 7.19 Funding and Investment Analysis: Regional Distribution
  • Figure 7.20 Global Events: Cumulative Half Yearly Trend, H1 2016-H2 2021
  • Figure 7.21 Global Events: Distribution by Type of Global Event (Virtual / Physical)
  • Figure 7.22 Global Events: Distribution by Type of Global Event (Conference / Webinar / Summit)
  • Figure 7.23 Global Events: Distribution by Location of Event
  • Figure 7.24 Most Active Event Organizers: Distribution by Number of Events
  • Figure 7.25 Most Active Participants: Distribution by Number of Events
  • Figure 7.26 Global Events: Distribution by Seniority Level of Participants
  • Figure 8.1 Patent Analysis: Distribution by Type of Patent
  • Figure 8.2 Patent Analysis: Cumulative Distribution by Publication Year, 2018-2022
  • Figure 8.3 Patent Analysis: Cumulative Distribution by Application Year, 2018-2022
  • Figure 8.4 Patent Analysis: Distribution by Geographical Location
  • Figure 8.5 Patent Analysis: Distribution by CPC Symbols
  • Figure 8.6 Word Cloud Analysis: Emerging Focus Areas
  • Figure 8.7 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization
  • Figure 8.8 Leading Industry Players: Distribution by Number of Patents
  • Figure 8.9 Leading Patent Assignees: Distribution by Number of Patents
  • Figure 8.10 Patent Analysis (Leading Industry Players): Benchmarking by Patent Characteristics (CPC Symbols)
  • Figure 8.11 Patent Analysis: Distribution of Patents by Age (2001-2020)
  • Figure 8.12 Needlestick Safety Injection Devices: Patent Valuation Analysis
  • Figure 9.1 Company Profiles: Leading Players
  • Figure 10.1 Needlestick Safety Injection Devices: Bowman Clock Pricing Strategy Matrix
  • Figure 10.2 Needlestick Safety Injection Devices: Bowman Clock Pricing Strategy Graphical Interpretation for Needles
  • Figure 10.3 Needlestick Safety Injection Devices: Bowman Clock Pricing Strategy Graphical Interpretation for Syringes
  • Figure 10.4 Needlestick Safety Injection Devices: Bowman Clock Pricing Strategy Graphical Interpretation for Other Types of Devices
  • Figure 11.1 Global Needlestick Safety Injection Devices Market, 2022-2035 (USD Billion)
  • Figure 11.2 Global Needlestick Safety Injection Devices Market: Distribution by Type of Device, 2022-2035 (USD Billion)
  • Figure 11.3 Global Needlestick Safety Injection Devices Market for Needles, 2022-2035 (USD Billion)
  • Figure 11.4 Global Needlestick Safety Injection Devices Market for Syringes, 2022-2035 (USD Billion)
  • Figure 11.5 Global Needlestick Safety Injection Devices Market for Other Types of Devices, 2022-2035 (USD Billion)
  • Figure 11.6 Global Needlestick Safety Injection Devices Market: Distribution by Purpose of Device, 2022-2035
  • Figure 11.7 Global Needlestick Safety Injection Devices Market for Devices Enabling Ease of Insertion / Retraction, 2022-2035 (USD Billion)
  • Figure 11.8 Global Needlestick Safety Injection Devices Market for Needle Shielding Devices, 2022-2035 (USD Billion)
  • Figure 11.9 Global Needlestick Safety Injection Devices Market for Devices Protecting Against Injuries, 2022-2035 (USD Billion)
  • Figure 11.10 Global Needlestick Safety Injection Devices Market: Distribution by Usability, 2022-2035
  • Figure 11.11 Global Needlestick Safety Injection Devices Market for Non- Reusable Devices, 2022-2035 (USD Billion)
  • Figure 11.12 Global Needlestick Safety Injection Devices Market for Reusable Devices, 2022-2035 (USD Billion)
  • Figure 11.13 Global Needlestick Safety Injection Devices Market: Distribution by Company Size, 2022-2035
  • Figure 11.14 Global Needlestick Safety Injection Devices Market for Very Small Companies, 2022-2035 (USD Billion)
  • Figure 11.15 Global Needlestick Safety Injection Devices Market for Small Companies, 2022-2035 (USD Billion)
  • Figure 11.16 Global Needlestick Safety Injection Devices Market for Mid-sized Companies, 2022-2035 (USD Billion)
  • Figure 11.17 Global Needlestick Safety Injection Devices Market for Large Companies, 2022-2035 (USD Billion)
  • Figure 11.18 Global Needlestick Safety Injection Devices Market for Very Large Companies, 2022-2035 (USD Billion)
  • Figure 11.19 Global Needlestick Safety Injection Devices Market: Distribution by Region, 2022 and 2035
  • Figure 11.20 Needlestick Safety Injection Devices Market in North America, 2022-2035 (USD Billion)
  • Figure 11.21 Needlestick Safety Injection Devices Market in Europe, 2022-2035 (USD Billion)
  • Figure 11.22 Needlestick Safety Injection Devices Market in Asia Pacific, 2022-2035 (USD Billion)
  • Figure 11.23 Needlestick Safety Injection Devices in Rest of the World, 2022-2035 (USD Billion)
  • Figure 12.1 Concluding Remarks: Market Landscape of Needlestick Safety Injection Devices
  • Figure 12.2 Concluding Remarks: Key Insights
  • Figure 12.3 Concluding Remarks: Product Competitiveness Analysis
  • Figure 12.4 Concluding Remarks: Partnerships and Collaborations
  • Figure 12.5 Concluding Remarks: Funding and Investments
  • Figure 12.6 Concluding Remarks: Global Events
  • Figure 12.7 Concluding Remarks: Patent Analysis
  • Figure 12.8 Concluding Remarks: Bowman Clock Pricing Strategy
  • Figure 12.9 Concluding Remarks: Market Forecast
  • Figure 12.10 Concluding Remarks: Market Forecast
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!